ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza

Lung-resident tissue macrophages generate Foxp3+regulatory T cells and promote airway tolerance

(2013) Pejman Soroosh et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Location, location, location: tissue-specific regulation of immune responses

(2013) Wei Hu et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Components of Streptococcus pneumoniae Suppress Allergic Airways Disease and NKT Cells by Inducing Regulatory T Cells

(2012) A. N. Thorburn et al.   JOURNAL OF IMMUNOLOGY

ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases

(2012) A. Baz Morelli et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Long-Term Antibody and Immune Memory Response Induced by Pulmonary Delivery of the Influenza Iscomatrix Vaccine

(2011) Ana Vujanic et al.   Clinical and Vaccine Immunology

Mechanisms of tolerance and allergic sensitization in the airways and the lungs

(2010) Maria A Curotto de Lafaille et al.   CURRENT OPINION IN IMMUNOLOGY

Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells

(2010) J. A. Preston et al.   EUROPEAN RESPIRATORY JOURNAL

Vaccination Strategies to Promote Mucosal Antibody Responses

(2010) Kang Chen et al.   IMMUNITY

Tolerizing allergic responses in the lung

(2010) C M Lloyd et al.   Mucosal Immunology

Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX™ adjuvanted recombinant antigens

(2010) Ana Vujanic et al.   VACCINE

Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing

(2008) J L K Wee et al.   Mucosal Immunology

Biomedical applications of sheep models: from asthma to vaccines

(2008) Jean-Pierre Y. Scheerlinck et al.   TRENDS IN BIOTECHNOLOGY